✦ LIBER ✦

The role of adjunctive immunotherapy in superficial bladder cancer

✍ Scribed by Kimio Fujita

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 304 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870615)59:12<2027::aid-cncr2820591210>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Superficial bladder cancer. Risk of recu

Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy

✍ Frank M. Torti; Bert L. Lum Pharmd 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Investigating centre effects in a multi-

Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer

✍ Takuhiro Yamaguchi; Yasuo Ohashi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

This paper examines the amount of variation among centres and estimates the overall e!ect of therapy in a multi-centre cancer clinical trial with censored failure time data. To investigate the centre e!ects, the variation in the treatment e!ect must be taken into consideration in addition to the var

Cancer of the bladder in southern Iran

✍ Ahmad Sadeghi; Shahla Behmard 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

What are the immunologically active comp

What are the immunologically active components of Bacille Calmette-Guérin in therapy of superficial bladder cancer?

✍ Alexandre R. Zlotta; Jean-Paul Van Vooren; Olivier Denis; Annie Drowart; Mamadou 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB

Anti-neoplastic activity of paclitaxel o

Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: In vivo and in vitro studies

✍ Ofer Nativ; Moshe Aronson; Ora Medalia; Tatiana Moldavsky; Edmond Sabo; Israel R 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

The effects of intravesical administration of paclitaxel (taxol) in a bladder tumor model in mice, as well as the drug's in vitro activity on the same tumor cells, have been studied. Two cell lines, derived from MBT-2 cells, were employed in these experiments. The T50 line (obtained by many passages

Use of cellular and cytokine adjuvants i

Use of cellular and cytokine adjuvants in the immunotherapy of cancer

✍ Salgaller, Michael L.; Lodge, Patricia A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

Cellular and cytokine adjuvants, often immune effector cells and soluble factors, respectively, are supplemental and/or follow-up treatments of human origin for cancer patients who have unsatisfactory clinical responses to conventional chemotherapy, radiotherapy, and surgery. Since many human studie